End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,390 KRW | 0.00% |
|
+0.63% | -6.03% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Merchandise
59.6
%
| 17,630 | 65.8 % | 18,119 | 59.6 % | +2.78% |
Refine - Antipyretic Analgesic and Anti-inflammatory Agent
10.7
%
| 2,492 | 9.3 % | 3,261 | 10.7 % | +30.85% |
Refine - Other Drugs, Etc
7.5
%
| 1,502 | 5.6 % | 2,276 | 7.5 % | +51.57% |
Refine - Other Digestive Medicines
5.9
%
| 1,560 | 5.8 % | 1,808 | 5.9 % | +15.86% |
Hard - Antiepileptic Drugs
5.3
%
| 1,023 | 3.8 % | 1,607 | 5.3 % | +57.04% |
Soft - Other Drugs, Etc
4.0
%
| 182 | 0.7 % | 1,226 | 4.0 % | +572.37% |
Hard - Other Drugs, Etc
3.9
%
| 1,246 | 4.7 % | 1,187 | 3.9 % | -4.78% |
Hard - Other Central Nervous System Drugs
3.0
%
| 862 | 3.2 % | 920 | 3.0 % | +6.74% |
Soft - Other Nutritional Supplements
0.9
%
| 143 | 0.5 % | 284 | 0.9 % | +99.06% |
Other
-0.9
%
| 109 | 0.4 % | -265 | -0.9 % | -343.46% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
97.7
%
| 26,233 | 97.9 % | 29,731 | 97.7 % | +13.34% |
International
2.3
%
| 565 | 2.1 % | 692 | 2.3 % | +22.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Beop-Pyo Lee
CEO | Chief Executive Officer | 59 | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Beop-Pyo Lee
CEO | Chief Executive Officer | 59 | 01/15/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,018,247 | 2,562,722 ( 36.52 %) | 0 | 36.52 % |
Company contact information
![address Baskhanbio Pharma Inc.(A354390)](https://cdn.zonebourse.com/static/address/141018639.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-6.03% | 3.22Cr | |
+55.95% | 81TCr | |
+43.62% | 64TCr | |
-6.98% | 35TCr | |
+19.08% | 33TCr | |
+9.05% | 30TCr | |
+16.30% | 25TCr | |
+2.41% | 22TCr | |
+12.47% | 22TCr | |
+8.91% | 17TCr |
- Stock Market
- Equities
- A354390 Stock
- Company Baskhanbio Pharma Inc.